Remove 2003 Remove Compliance Remove FDA
article thumbnail

HHS-OIG Excludes Theranos Founder and CEO from Federal Health Programs for 90 Years

HIPAA Journal

The Theranos Scandal Theranos was a blood testing startup founded by Elizabeth Holmes in 2003. The FDA launched an investigation into Theranos that found that the allegations in Carreyrou’s article were correct. The company was investigated by the Federal Bureau of Investigation and shut down.

Fraud 82
article thumbnail

Building a Quality Education Program That’s Good Enough 

YouCompli

If you are in clinical research, this means looking at the FDA requirements, ICH-GCP Guidelines, and other applicable regulations. He has worked in clinical research since 2003 and is inspired by the Irish professional wrestler Becky Lynch, whose personal and professional story centers on achievement, tenacity, grit, and overcoming adversity.

Nurses 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthcare Cybersecurity – 2024 Health IT Predictions

Healthcare IT Today

Jennifer Hennessy, Partner at Foley & Lardner LLP In 2024, regulators will make efforts to better align laws with modern cybersecurity risk – and organizations will need to assess their cybersecurity programs for compliance with these updates.

article thumbnail

Which Situations Allow a Medical Professional to Release Information?

HIPAA Journal

The page reveals that, since 2003, the agency has received more than 300,000 complaints alleging violations of HIPAA. To the HHS’ Office for Civil Rights in response to a patient complaint or compliance audit. To the Federal Drug Administration to report adverse events and track FDA-regulated products.

HIPAA 74
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – May And June

SQA

Personal Care Products Council (PCPC) PCPC MoCRA Toolkit, May 2023 Enacted in December 2022, the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) represents years of efforts by the Personal Care Products Council, the FDA, Congress, and other stakeholders to modernize the U.S. cosmetic regulatory framework.

FDA 40
article thumbnail

Logical Contradiction Doctrine:  Buckman for Textualists

Drug & Device Law

470 (1996), was decided – removing express preemption as a defense for manufacturers of §510(k) products So defendants moved on fraud on the FDA under an implied preemption theory and won. Plaintiffs Legal Committee , 531 U.S. Mensing , 564 U.S. Mensing , 564 U.S. Lohr , 518 U.S.

FDA 72